Epicardial Fat Thickness and Heart Risk in Adults Aged 50-70
Official title: Epicardial Fat Tissue Assessed by Echocardiography in Russian and Asian Populations: Association With Chronic Non-Communicable Diseases and Risk Factors
Run by National Medical Research Center for Therapy and Preventive Medicine · NCT07604610 · Data updated 2026-11-12
This study will see if the thickness of epicardial fat helps predict heart and metabolic risks in adults aged 50-70 from several countries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 70 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | National Medical Research Center for Therapy and Preventive Medicine Government |
| Locations | 1 site (Moscow) |
| Status | Recruiting |
| Started | May 4, 2026 |
| Main results expected | March 2027 |
| Study ends | March 2028 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07604610 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50-70 undergoing transthoracic echocardiography who can consent and have suitable image quality.
✕Probably not a fit
Patients with unsuitable echocardiographic images or those outside the age range may not derive direct benefit from EFT measurements in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will measure epicardial fat tissue (EFT) thickness using transthoracic echocardiography and relate it to clinical, laboratory, and anamnestic data. It will examine how EFT correlates with cardiac structure and function, and with other risk factors associated with metabolic and cardiovascular disease. The study will identify EFT thresholds linked to myocardial remodeling and will follow participants by phone to track outcomes and the prognostic value of EFT thickness for a composite endpoint. Data will come from patients undergoing echocardiography in Russia and Central Asia, with a focus on aging populations at risk for non-communicable diseases.
Why it matters
Potential benefit: If EFT thickness proves a strong prognostic marker, clinicians could better stratify cardiovascular risk and tailor preventive strategies.
How similar studies have gone: Previous research has linked EFT with cardiovascular and metabolic risk, but this specific multinational cohort focuses on threshold values and prognosis, representing a relatively novel approach in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings; * Ability and willingness to provide informed consent. Exclusion Criteria: * Refusal to sign informed consent; * Inability to perform transthoracic echocardiography or poor image quality; * Severe psychiatric disorders.
Where it's running
-
National Medical Research Center for Therapy and Preventive Medicine
Moscow, Russia Recruiting
Study contacts
- Study coordinator: Olga Dzhioeva, MD, Associate Professor
- Email: odzhioeva@gnicpm.ru
- Phone: +79166141821
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of dietary phosphate on exercise and body fat
This study is testing if eating less phosphate can help healthy adults exercise better and manage their body fat more effectively.
-
Low-calorie, high-protein diet before weight-loss surgery
This project will try whether a short low-calorie, high-protein diet before sleeve gastrectomy reduces liver fat and weight in adults with severe obesity.
-
Community-based care for chronic diseases in rural Lesotho
This study tests if community health workers in rural Lesotho can effectively help manage chronic diseases like diabetes and hypertension using new technology and regular check-ups.
-
Long-term follow-up of endocrine and metabolic changes after gestational diabetes
This project will follow women who had gestational diabetes and their children to see if pregnancy and early-life measurements predict later chronic diseases.
-
Graphic health warnings plus pharmacist counseling to help people quit smoking
This project will test whether combining graphic health warnings with pharmacist-led counseling helps adult smokers in Bangladesh and Pakistan quit.
-
Using the WARIFA app to promote healthy lifestyles and manage Type 1 Diabetes
This study is testing whether the WARIFA app can help people with Type 1 Diabetes and those with other health conditions live healthier lives by giving them personalized tips.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.